EIF4E and cancer: The idea of using cap analogues for therapeutic purposes came with reports that an elevated level of eIF4E is associated with tumor formation and progression in human malignancies and cancers of the breast, colon, bladder, prostate, lung, head, and neck (Figure 2, the top row) [5,6,7].